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The term ‘‘peripheral node addressins’’ describes a
set of several endothelial adhesion molecules, which
collectively bind to L-selectin and react with mono-
clonal antibody MECA-79. They regulate lymphocyte
recirculation through peripheral nodes. Their expres-
sion is thought to be restricted to a specialized vascular
segment within the node, called the high endothelial
venule. In certain chronic skin diseases, however,
postcapillary venules of the skin may also acquire a
high endothelial venule-like morphology. Employing
immunohistochemistry on cryostat sections, we found
these skin endothelial cells – like peripheral node high
endothelial venules – to be reactive with monoclonal
antibody MECA-79. Tissue lysates from the same
specimens were then analyzed by immunoprecipi-
tation using recombinant human L-selectin Fc-chi-
meras followed by immunoblotting using monoclonal
antibody MECA-79. In contrast to peripheral node
In order to populate and continuously recirculate throughperipheral lymph nodes, lymphocytes utilize a distinct celladhesion molecule, L-selectin, expressed on their cell surface.The biologic importance of L-selectin was demonstrated byexperiments showing that L-selectin-deficient lymphocytes
are unable to enter peripheral nodes (Arbones et al, 1994; Steeber
et al, 1996; Tang et al, 1998). As a functional consequence,
lymphocytes cannot ‘‘see’’ antigens presented by antigen-presenting
cells within the regional nodes, which results in impaired sensitiza-
tion (Catalina et al, 1996).
L-selectin exerts this function by binding to ligands expressed on
a specialized vascular segment within the node, called the high
endothelial venule (HEV). Most of the current knowledge about
these ‘‘node-specific L-selectin ligands’’ is derived from studies using
monoclonal antibody (MoAb) MECA-79. This antibody reacts
with sialylated, fucosylated, and sulfated carbohydrates (sulfo-sLex)
coupled to a diverse set of glycoproteins and blocks lymphocyte
homing to peripheral nodes (Streeter et al, 1988; Hemmerich
et al, 1994). Therefore, these MECA-79-reactive L-selectin ligands
expressed on HEV have been collectively called peripheral node
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endothelium, which mainly expressed peripheral node
addressin moieties of molecular sizes 90–110 kDa and
160 kDa, endothelial cells in cutaneous T cell
lymphoma skin lesions expressed an additional and
not yet defined 220 kDa peripheral node addressin-
like molecule. Most surprisingly, even in normal skin
specimens, we found a distinct subset of endothelial
cells located around hair follicles constitutively
expressing 90–110 kDa peripheral node addressin-like
moieties. It is intriguing to speculate that – in analogy
to the role of peripheral node addressins in peripheral
nodes – the induced expression of peripheral node
addressins in chronic T cell mediated skin diseases is
responsible for a sustained lymphocyte recruitment.
The constitutive expression of peripheral node
addressins on perifollicular endothelium may serve for
a continuous lymphocyte recirculation through normal
skin. Key words: L-selectin ligands/MECA-79/skin micro-
vasculature. J Invest Dermatol 113:410–414, 1999
addressins (PNAd). PNAd isolated from human lymph nodes and
tonsils encompasses several glycoproteins of molecular weights 50–
60, 90–110, 160, and 200 kDa (Berg et al, 1991; Suzuki et al, 1996;
Sassetti et al, 1998). CD34 represents a part of the 90–110 kDa
component and the 160 kDa molecule is a podocalyxin-like protein,
whereas the identities of the remaining proteins of the ‘‘PNAd
complex’’ in humans are as yet unknown (Berg et al, 1991;
Baumhueter et al, 1993; Puri et al, 1995; Sassetti et al, 1998). PNAd
has to be separated from MECA-79-nonreactive L-selectin ligands,
such as PSGL-1 or ELAM-1, which do not function as lymph
node homing receptors and have an altered tissue distribution (Imai
et al, 1993; Kogelberg and Rutherford, 1994; Tu et al, 1996;
Sackstein et al, 1997; Zo¨llner et al, 1997; Berg et al, 1998; Clark
et al, 1998; Snapp et al, 1998).
Based on the observation that postcapillary venules in certain
chronic skin diseases such as psoriasis, pseudolymphoma, and T
cell lymphoma acquire a HEV-like morphology, similar to that
seen in peripheral nodes (Streilein, 1990), we set out to explore,
whether these skin endothelial cells also acquire a HEV-like
phenotype, namely the expression of L-selectin ligands of the
PNAd complex.
MATERIALS AND METHODS
Human tissues Human lymph nodes from the axillary and inguinal
region and normal human skin from the thighs, limbs, and trunk were
obtained from cadaveric donors through the Department of Pathology,
University of Vienna, according to an approved protocol of the University
of Vienna Ethical Committee. Biopsies from cutaneous T cell lymphoma
skin lesions (plaque and tumor stage of mycosis fungoides) were obtained
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Figure 1. Skin endothelial cells react with MoAb MECA-79. Immunohistochemistry on frozen tissue sections: (a) nodular cutaneous T cell
lymphoma lesional; (b, c) HEV-like vessels in cutaneous T cell lymphoma lesions; (d) superficial vascular plexus of normal skin; (e, f) perifollicular vessels
of normal skin; (g, h) peripheral lymph node. All images except f and h show MECA-79 staining, f and h are isotype IgM stainings. Scale bar: 0.1 mm
from five different patients after informed consent. After removing the
subcutaneous tissue, all samples were immediately snap frozen and stored
in liquid nitrogen. For selected experiments, dermal microvascular endo-
thelial cells were isolated from 100 cm2 normal cadaveric thigh skin by
dispase digestion followed by mechanical expression of cells into phosphate-
buffered saline as described previously (Petzelbauer et al, 1995). The
expressed cells contained approximately 5 3 105 endothelial cells per
sample. After pelleting they were immediately snap frozen and stored in
liquid nitrogen.
Immunohistochemistry Five micrometer cryostat sections were pre-
pared and three step immunohistochemistry using the avidin–biotin system
(peroxidase ABC-Elite kit; Vector Laboratories, Burlingame, CA) was
performed as described previously (Kunstfeld et al, 1997). As first step
reagents, we used MoAb MECA-79 (rat anti-mouse antibody, IgM;
Pharmingen, San Diego, CA) or an isotype control antibody diluted 1:1000
in phosphate-buffered saline containing 3% rabbit serum. The second step
antibody was a biotin-conjugated rabbit anti-rat IgM from Jackson (West
Grove, PA).
Immunoprecipitation Frozen tissues (µ200 mg per experiment) were
cut into pieces, submersed in 1 ml lysis buffer containing 50 mM Tris,
2 mM CaCl2, 2 mM MnCl, 2 mM MgCl, 2% NP-40, and 1 mM
phenylmethylsulfonyl fluoride, 10 µg per ml aprotinin, 15 µg per ml
leupeptin, pH 7.5, and homogenized using the Dispersing-Tool from IKA
(Stauffen, Germany). Following 1 h incubation on ice, centrifugation at
13,000 3 g for 20 min at 4°C, the supernatants were collected and
precleared with protein G Sepharose beads (GammaBind G; Pharmacia,
Uppsala, Sweden). For selective experiments, endothelial cells were isolated
from cadaveric thigh skin by dispase digestion as described above. Endothel-
ial cells were submersed in lysis buffer as described for full skin samples.
For immunoprecipitation of L-selectin ligands, 50 µg protein G Sepharose
beads (Sigma, St Louis, MO) were loaded with 25 µg L-selectin–Fc
protein (gift from Ray Camphausen, Genetics Institute, Cambridge, MA).
Alternatively, 50 µg protein G Sepharose beads were loaded with 10 µg
anti-rat IgM antibody (Jackson) followed by incubation with 20 µg MECA-
79. As a negative control, beads were loaded with 25 µg L-selectin–Fc
chimeric protein in the presence of 10 M ethylenediamine tetraacetic acid,
as it has been shown previously that the L-selectin/L-selectin ligand
interaction is Ca21 sensitive (Sassetti et al, 1998). To control for the
precipitation with MoAb MECA-79, the specific MoAb was replaced by
an irrelevant rat IgM. The respective beads were incubated with lysates
derived from µ200 mg tissue for 2 h at 4°C under continuous rotation.
Beads were then pelleted by centrifugation at 3000 3 g, washed in 50 mM
Tris buffer, pH 7.5, containing 2 mM CaCl2, 2 mM MnCl, 2 mM MgCl,
and immunoprecipitates were eluted using a 2 3 sample buffer (62.5 mM
Tris/HCl, pH 6.8, 10% glycerol, 1% sodium dodecyl sulfate, 10 µg
bromophenol blue per ml, 2% β-mercaptoethanol) for 5 min at 95°C.
Immunoblotting Precipitated proteins were separated by polyacryl-
amide gel electrophoresis under reducing conditions according to the
method described by Laemmli (1970). After electrotransfer on to nitrocellu-
lose membranes (BioRad, Richmond, CA), incubation with MECA-79
(5 µg per ml) in 50 mM Tris-buffered saline, pH 7.5, containing 1% low-
fat milk, rinsing, incubation with a horseradish peroxidase-conjugated
second step antibody (Pierce, Rockford, IL), peroxidase was visualized by
chemiluminescence (Amersham Corporation, Buckinghamshire, U.K.) and
recorded on film. Appropriate isotype controls were run in parallel.
RESULTS AND DISCUSSION
Tissue distribution of MECA-79-reactive epitopes in T cell
lymphoma skin lesions and in normal skin Screening lesional
skin from chronic eczema (n 5 3), psoriasis (n 5 4), parapsoriasis
(n 5 8), and cutaneous T cell lymphoma (n 5 5) by immunohisto-
chemistry for the expression of MECA-79-reactive epitopes
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Figure 2. PNAd on skin endothelial cells. Immunoprecipitation with
recombinant human L-selectin–Fc chimeric protein; precipitated proteins
were electrophoresed, immunoblots were performed using MoAb MECA-
79 for detection. The respective lanes were loaded with full lysates (L),
with the supernatants after removing L-selectin ligands by precipitation(s)
and with L-selectin precipitates (P). HK, MA, and HV are three different
individuals with cutaneous T cell lymphoma skin lesions used for the
respective experiment. LNN, lymph node; DMEC, dermal microvascular
endothelial cells freshly isolated from normal human skin; HUVEC, human
umbilical vein endothelial cells. Closed arrows point to the 220 kDa bands,
open arrows to the 110 kDa bands.
Figure 3. MECA-79 is specific for L-selectin ligands. Immuno-
precipitation with MoAb MECA-79, precipitated proteins were
electrophoresed, immunoblots were performed using MoAb MECA-79 as
the detection antibody. The respective lanes were loaded with full lysates
(L), with the material precipitated with empty beads (b), with the
supernatants after removing L-selectin ligands by precipitation (s) and with
L-selectin precipitates (P). Please note, that detected proteins match by size
with those precipitated with L-selectin and detected with MECA-79, see
Fig 2. The arrow points to the IgM antibody used for precipitation.
revealed that both, the numbers of positively stained vessels within
the superficial vascular plexus as well as their relative staining
intensity was most abundant in patch and tumor stages of cutaneous
T cell lymphoma lesions (data shown for T cell lymphoma only;
Fig 1a–c). This has been reported previously (Mackay et al, 1992;
Michie et al, 1993), but we wish to draw attention to the fact
that all endothelial cells reactive with MECA-79 had acquired
morphologic features of HEV, being of a cuboidal shape with large
and prominent nuclei (Fig 1b, c). In normal skin samples, endothelial
cells within the superficial vascular plexus were reproducibly
negative for MECA-79 (Fig 1d). Most interestingly, screening
normal skin samples from 10 different donors by serial sectioning
revealed 20%–60% of hair follicles being surrounded by MECA-
79-positive vessels (Fig 1e). It should be noted that endothelial
cells from the perifollicular vascular segment differ by morphology
from the superficial vascular plexus endothelium by having bridged
fenestrations (Braverman and Keh, 1981).
HEV in peripheral nodes, investigated as a positive control,
showed a staining pattern with MoAb MECA-79 very similar to
that observed in tumor stages of cutaneous T cell lymphoma lesions
(Fig 1). Moreover, immunohistochemistry revealed a striking
specificity of MoAb MECA-79 for endothelium, hematopoietic
cells always being nonreactive for MECA-79 (Fig 1). As an
additional control for the specificity of MECA-79, peripheral blood
nuclear cells were tested for MECA-79 expression by fluorescence-
activated cell sorter and this also resulted in a negative staining
(data not shown).
PNAd in cutaneous T cell lymphoma lesions We next
addressed the question whether these MECA-79-reactive epitopes
found on skin endothelium are indeed L-selectin ligands or even
resemble PNAd molecules. For these experiments we chose cutane-
ous T cell lymphoma lesions, because of the abundance of endothel-
ial MECA-79 reactivity. Detergent lysates of lesional skin from five
different patients were analyzed. Lysates from four patients gave
reproducible results in at least two independent experiments each,
material from the fifth patient was not sufficient for an independent
repeat and was therefore excluded from this study. From each of
the four lysates, L-selectin precipitated a pattern of MECA-79-
reactive proteins of molecular weights of 90–110 kDa, 160 kDa,
200 kDa, and 220 kDa (Fig 2). Fifty to 60 kDa proteins were only
found in one patient (HK; Fig 2). With the exception of the
220 kDa component, the pattern of these skin-derived MECA-
79-reactive L-selectin ligands exactly matched the PNAd complex
isolated from peripheral nodes, which were examined as a positive
control (Fig 2). In peripheral nodes, the 220 kDa component was
either absent or not clearly separable from the 200 kDa protein
(Fig 2). As a negative control, precipitation with the L-selectin–Fc
chimeric protein in the presence of Ca21 was performed, the
subsequent immunoblot of these precipitates did not reveal any
MECA-79-reactive proteins (data not shown).
To control for the possibility that the MECA-79-reactive L-
selectin ligands detected in our skin samples were expressed by
infiltrating white blood cells, peripheral blood nuclear cells were
analyzed for comparison. In these cells, L-selectin precipitated the
240 kDa dimeric protein PSGL-1, a MECA-79 nonreactive L-
selectin ligand expressed on lymphocytes, but no MECA-79-
reactive proteins (data not shown). This experiment confirmed our
immunohistochemical observation that MoAb MECA-79 reacts
exclusively with endothelial epitopes and not with leukocytes.
We next subjected skin lysates to MECA-79 immunoprecipi-
tation followed by immunoblotting using MoAb MECA-79 for
detection. The molecular sizes of proteins detected by this procedure
matched those precipitated by L-selectin and detected by MECA-
79 immunoblotting (Fig 3). These experiments do not prove
but strongly suggest that virtually all MECA-79-reactive epitopes
detected in our skin samples stand for L-selectin ligands ‘‘of the
PNAd type’’.
PNAd in normal skin samples In seeming contrast with our
immunohistochemical observation that MoAb MECA-79 reacted
with perifollicular endothelial cells, we were unable to precipitate
L-selectin ligands from normal skin samples when lysing 200 mg
of tissue for one experiment (Fig 2). We attributed this to the fact
that L-selectin ligands were below the detection limit and tried to
enrich for L-selectin ligands. For this purpose, L-selectin-Fc-protein
G Sepharose beads were incubated with lysates from normal
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skin, centrifuged and reincubated with another fresh lysate. This
procedure was repeated up to five times. In the following blot,
MoAb MECA-79 now detected a faint band of µ110 kDa (Fig 2).
As this result was still unsatisfactory, we isolated microvascular
endothelial cells by dispase digestion, a technique, which is routinely
used for generating microvascular endothelial cell cultures. The
resulting cell suspension was lysed and subjected to precipitation
with L-selectin, electrophoresed, and blotted. Now MoAb MECA-
79 clearly detected a 110 kDa protein band and two other
low molecular weight bands (most likely artifacts due to dispase
treatment). We next analyzed MECA-79 expression on dermal
microvascular endothelial cells placed in cell culture and passaged
as described previously (Petzelbauer et al, 1995). Unfortunately,
neither cultured human foreskin-derived nor cultured adult human
thigh skin-derived endothelium reacted with MoAb MECA-79
(data not shown). This indicated that cell culture either selected
for MECA-79 negative cells or resulted in a downregulation of
these moieties, which prevented further characterization of the
nature of the 110 kDa L-selectin ligand expressed on perifollicular
endothelium seen in situ. For comparison, human umbilical vein
endothelial cells were also subjected to the same procedure and
did not reveal any MECA-79 reactivity.
CONCLUSIONS
These experiments show that L-selectin ligands of the ‘‘PNAd type’’
are not a specific feature of peripheral node HEV, but are also
expressed on skin endothelial cells. By size, these MECA-79-
reactive L-selectin ligands detected in T cell lymphoma skin largely
corresponded to proteins of the PNAd complex expressed on
peripheral lymph node HEV. We want to emphasize, however,
that skin endothelial cells expressed an additional PNAd-like
220 kDa protein, which has yet not been identified and extents
the list of proteins capable of holding PNAd moieties. This 220 kDa
protein appears to be preferentially expressed by skin endothelium
and is absent or expressed in very low levels on peripheral node
HEV. It should be noted that Sassetti et al (1998) were able to
identify a .200 kDa protein in human tonsils, which they postulated
to represent a multimer of the 160 kDa podocalyxin-like protein.
Whether the herein described 220 kDa protein represents a
podocalyxin multimer remains to be determined. For obvious
reasons, the availability of sufficiently large samples of diseased
human skin is limited and we thus have not yet succeeded in
characterizing the protein backbone of this 220 kDa L-selectin
ligand.
Yet, the role of PNAd-like L-selectin ligands within the skin
remains speculative. The 110 kDa PNAd-like molecule constitu-
tively expressed on perifollicular endothelium might be part of the
continuous lymphocyte recirculation pathway through the skin
used for regional sensitization or tolerance development (Enk and
Katz, 1995; Alfernik et al, 1998). The situation appears different
with regard to the induced expression of PNAd-like molecules on
superficial vascular plexus endothelium in T cell mediated diseases.
In the early phase of inflammation, superficial vascular plexus
endothelium expresses molecules such as P-selectin, E-selectin, and/
or VCAM-1, whereas MECA-79 reactivity is absent (Whyte
et al, 1996). In line with this immunohistochemical observation,
employing L-selectin(–/–) mice, Catalina et al (1999) demonstrated
that during the first 20 h after skin challenge, P-selectin and E-
selectin but not L-selectin were crucial for the development of
both, irritant-induced as well as allergen-induced skin inflammation.
In the late phase of skin inflammation and, most abundant, in
chronic T cell mediated skin diseases such as psoriasis and cutaneous
T cell lymphoma, the superficial vascular plexus endothelium
acquires robust MECA-79 reactivity (Michie et al, 1993; Whyte
et al, 1996). In a sheep model analyzing tuberculin reactions within
the skin, MECA-79 expression did not appear before day 3 after
antigenic challenge (Mackay et al, 1992). In a mouse model,
skin graft rejection was delayed and numbers of infiltrating T
lymphocytes reduced in L-selectin(–/–) mice as compared with
L-selectin(1/1) littermates, despite the fact that cytotoxic T cell
responses in L-selectin(–/–) mice equaled those seen in L-selectin(1/
1) controls, indicating an impaired migration of effector cells rather
than an impaired cytotoxic T cell response (Tang et al, 1997). An
apparent difference in graft rejection between L-selectin(–/–) and
(1/1) mice was not observable before day 4. Taken together,
these data indicate that L-selectin does not play a part in skin
inflammation before days 3–4 after initiation of the inflammatory
reaction.
Whether the switch to PNAd-like adhesion molecule moieties
in chronic skin diseases is an attempt of the organism to change
patterns of recruited white blood cells, remains to be elucidated.
Anyway, such a concept would be in line with the fact that acute
inflammatory infiltrates mainly consist of CD45RO memory type
cells (Sterry et al, 1990), whereas chronic skin diseases, such as
chronic cutaneous lupus (Rijlaarsdam et al, 1990) and cutaneous T
cell lymphoma lesions (unpublished observation) contain consider-
able numbers of CD45RA positive T cells. This assumption is
further supported by Mackay’s sheep model where the authors
found an association between MECA-79 expression on skin endo-
thelium and the appearance of naı¨ve T cells within the draining
lymphatic vessel (Mackay et al, 1992).
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